Placebo and Nocebo Effects in Patients With Takotsubo Cardiomyopathy and Heart-Healthy Controls.
cardiological response
nocebo effects
placebo effects
sympathetic nervous system
takotsubo cardiomyopathy
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2019
2019
Historique:
received:
14
12
2018
accepted:
15
07
2019
entrez:
21
8
2019
pubmed:
21
8
2019
medline:
21
8
2019
Statut:
epublish
Résumé
The etiology of takotsubo cardiomyopathy (TTC)-a rare, reversible, and acquired form of cardiac diseases-is not yet fully explained. An exaggerated activation of the sympathetic-nervous-system (SNS) following stressful psychosocial life events is discussed to be of key importance. In this experimental study, we tested whether TTC patients, compared to heart-healthy controls, respond more strongly to supporting placebo interventions and stressful nocebo interventions targeting cardiac function. In a single experimental session, 20 female TTC patients and 20 age matched (mean age 61.5 years, ± 12.89) catheter-confirmed heart-healthy women were examined. Saline solution was administered three times i.v. to all participants, with the verbal suggestion they receive an inert substance with no effects on the heart (neutral condition), a drug that would support cardiac functions (positive condition), and a drug that would burden the heart (negative condition). Systolic and diastolic blood pressure (DBP/SBP), heart rate (HR), endocrine markers cortisol (µg/dl), copeptin (pmol/l), and subjective stress ratings (SUD) were assessed to examine alterations of the SNS and the hypothalamic-pituitary-adrenal axis (HPA). Before and after each intervention SUD was rated. One pre and three post serum cortisol and copeptin samples were assessed, and a long-term electrocardiogram as well as non-invasive, continuous blood pressure was recorded. The study design elucidated a significant increase of SUD levels as a response to the nocebo intervention, while perceived stress remained unaffected during the preceding neutral and positive interventions. Increasing SUD levels were accompanied by higher SBP and an anticipatory increase of HR shortly prior to the nocebo intervention. SBP increased also as a response to positive verbal suggestions (Bonferroni-corrected p-values > .05). Alterations of cortisol and copeptin due to the interventions and significant placebo effects failed to appear. Interestingly no differences between TCC patients and controls could be found.These findings do not support the assumption of an exaggerated activation of the SNS as a discriminatory factor for TTC. Since especially the nocebo intervention revealed negative subjective and objective effects, our results underscore the urgent need to consider carefully the impact of verbal suggestions in the interaction with cardiac patients in daily clinical routine. This study is registered at the Deutsches Register Klinischer Studien (DRKS00009296).
Identifiants
pubmed: 31428002
doi: 10.3389/fpsyt.2019.00549
pmc: PMC6688659
doi:
Types de publication
Journal Article
Langues
eng
Pagination
549Références
J Neurosci. 1999 May 1;19(9):3639-48
pubmed: 10212322
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9281-6
pubmed: 10908676
Science. 2001 Aug 10;293(5532):1164-6
pubmed: 11498597
Science. 2002 Mar 1;295(5560):1737-40
pubmed: 11834781
Am Heart J. 2002 Mar;143(3):448-55
pubmed: 11868050
J Neurosci. 2002 Apr 15;22(8):3206-14
pubmed: 11943821
Pain. 2002 Oct;99(3):443-52
pubmed: 12406519
J Neurosci. 2003 May 15;23(10):4315-23
pubmed: 12764120
Psychosom Med. 2003 Sep-Oct;65(5):786-90
pubmed: 14508021
Science. 2004 Feb 20;303(5661):1162-7
pubmed: 14976306
J Clin Endocrinol Metab. 2005 Aug;90(8):4579-86
pubmed: 15886236
Peptides. 2005 Dec;26(12):2500-4
pubmed: 15922490
Circulation. 2006 Apr 11;113(14):1807-16
pubmed: 16567565
Eur Heart J. 2006 Jul;27(13):1523-9
pubmed: 16720686
Int J Cardiol. 2007 Sep 3;120(3):411-3
pubmed: 17098304
Am J Cardiol. 2007 Jan 15;99(2):182-5
pubmed: 17223415
Neuroscience. 2007 Jun 29;147(2):260-71
pubmed: 17379417
Chest. 2007 Sep;132(3):809-16
pubmed: 17573507
J Am Coll Cardiol. 2007 Jul 31;50(5):448-52
pubmed: 17662398
Curr Opin Anaesthesiol. 2007 Oct;20(5):435-9
pubmed: 17873596
Pain. 2008 May;136(1-2):211-8
pubmed: 18372113
Neuro Endocrinol Lett. 2008 Jun;29(3):341-6
pubmed: 18580851
Trends Cogn Sci. 2008 Aug;12(8):306-13
pubmed: 18606561
Eur J Heart Fail. 2008 Oct;10(10):1015-9
pubmed: 18692439
Am Heart J. 2008 Sep;156(3):543-8
pubmed: 18760139
Physiol Behav. 2009 Apr 20;97(1):102-6
pubmed: 19419665
Pain. 2009 Sep;145(1-2):24-30
pubmed: 19523766
J Am Coll Cardiol. 2010 Jan 26;55(4):333-41
pubmed: 20117439
Clin Cardiol. 2010 May;33(5):307-10
pubmed: 20513070
Ann Intern Med. 2010 Jun 15;152(12):830-1
pubmed: 20547921
Herz. 2010 Jun;35(4):240-3
pubmed: 20582391
Behav Brain Sci. 2010 Aug;33(4):245-66; discussion 266-313
pubmed: 20964882
Psychosom Med. 2011 Feb-Mar;73(2):193-9
pubmed: 21217098
Pain. 2011 Jul;152(7):1486-94
pubmed: 21353388
Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1808-17
pubmed: 21576138
BMJ. 2011 Aug 11;343:d4345
pubmed: 21835868
Am Heart J. 2011 Sep;162(3):507-11
pubmed: 21884868
Pain. 2012 May;153(5):1114-21
pubmed: 22464696
Am Heart J. 2012 Jul;164(1):66-71.e1
pubmed: 22795284
Neuroimage. 2013 Feb 15;67:227-36
pubmed: 23201367
Pain. 2013 Apr;154(4):511-4
pubmed: 23473783
J Psychosom Res. 2013 Jul;75(1):32-5
pubmed: 23751235
JAMA Intern Med. 2013 Nov 25;173(21):1941-51
pubmed: 24126676
Circulation. 2014 Apr 22;129(16):1659-67
pubmed: 24503950
J Neurosci. 2014 Mar 26;34(13):4634-9
pubmed: 24672009
Am J Cardiol. 2014 Apr 15;113(8):1420-8
pubmed: 24685327
Pain. 2014 Aug;155(8):1426-34
pubmed: 24780622
Int J Cardiol. 2014 Jul 1;174(3):696-701
pubmed: 24809923
Handb Exp Pharmacol. 2014;225:183-203
pubmed: 25304533
Hum Brain Mapp. 2015 May;36(5):1648-61
pubmed: 25529840
J Invest Dermatol. 2015 May;135(5):1234-1243
pubmed: 25609025
Int J Cardiol. 2015 Apr 15;185:282-9
pubmed: 25818540
N Engl J Med. 2015 Sep 3;373(10):929-38
pubmed: 26332547
Eur J Cardiovasc Nurs. 2016 Dec;15(7):522-528
pubmed: 26572162
Eur Heart J. 2016 Oct 01;37(37):2823-2829
pubmed: 26935270
Eur Heart J. 2016 Oct 01;37(37):2821-2822
pubmed: 27252450
Heart Fail Clin. 2016 Oct;12(4):485-98
pubmed: 27638019
Int J Cardiol. 2017 May 15;235:87-93
pubmed: 28262347
Ann Behav Med. 2017 Dec;51(6):925-930
pubmed: 28417437
J Am Coll Cardiol. 2017 Aug 22;70(8):975-991
pubmed: 28818208
J Am Coll Cardiol. 2017 Aug 22;70(8):992-995
pubmed: 28818209
Int Rev Neurobiol. 2018;138:95-111
pubmed: 29681337
Eur Heart J. 2018 Jun 7;39(22):2032-2046
pubmed: 29850871
Psychosom Med. 1982 Sep;44(4):389-95
pubmed: 6755527
J Hypertens. 1993 Mar;11(3):293-6
pubmed: 8387087
Pain. 1997 Aug;72(1-2):107-13
pubmed: 9272794
Am J Physiol. 1998 Sep;275(3):R720-7
pubmed: 9728068